These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24128166)

  • 1. Clinical outcome and cyclo-oxygenase-2 expression in five dogs with solar dermatitis/actinic keratosis treated with firocoxib.
    Albanese F; Abramo F; Caporali C; Vichi G; Millanta F
    Vet Dermatol; 2013 Dec; 24(6):606-12, e147. PubMed ID: 24128166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of firocoxib and tepoxalin on healing in a canine gastric mucosal injury model.
    Goodman L; Torres B; Punke J; Reynolds L; Speas A; Ellis A; Budsberg S
    J Vet Intern Med; 2009; 23(1):56-62. PubMed ID: 19175721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma.
    Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M
    Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
    Arenas C; Peña L; Granados-Soler JL; Pérez-Alenza MD
    Vet Rec; 2016 Jul; 179(5):125. PubMed ID: 27377395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
    Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
    J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs.
    Drag M; Kunkle BN; Romano D; Hanson PD
    Vet Ther; 2007; 8(1):41-50. PubMed ID: 17447224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
    Autefage A; Palissier FM; Asimus E; Pepin-Richard C
    Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
    Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C
    Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis.
    Cathcart CJ; Johnston SA; Reynolds LR; Al-Nadaf S; Budsberg SC
    Am J Vet Res; 2012 Jan; 73(1):19-26. PubMed ID: 22204284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
    Pollmeier M; Toulemonde C; Fleishman C; Hanson PD
    Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
    Ryan WG; Moldave K; Carithers D
    Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance of firocoxib in dogs with osteoarthritis during 90 days.
    Lecoindre O; Pepin-Richard C
    J Vet Pharmacol Ther; 2011 Apr; 34(2):190-2. PubMed ID: 21395612
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the analgesic efficacy of perioperative firocoxib and tramadol administration in dogs undergoing tibial plateau leveling osteotomy.
    Davila D; Keeshen TP; Evans RB; Conzemius MG
    J Am Vet Med Assoc; 2013 Jul; 243(2):225-31. PubMed ID: 23822079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.
    Vijarnsorn M; Kwananocha I; Kashemsant N; Jarudecha T; Lekcharoensuk C; Beale B; Peirone B; Lascelles BDX
    BMC Vet Res; 2019 Oct; 15(1):349. PubMed ID: 31623621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia.
    McCann ME; Rickes EL; Hora DF; Cunningham PK; Zhang D; Brideau C; Black WC; Hickey GJ
    Am J Vet Res; 2005 Jul; 66(7):1278-84. PubMed ID: 16111170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of COX-2 in feline and canine actinic keratoses and cutaneous squamous cell carcinoma.
    Bardagí M; Fondevila D; Ferrer L
    J Comp Pathol; 2012 Jan; 146(1):11-7. PubMed ID: 21601872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score.
    Campione E; Diluvio L; Paternò EJ; Chimenti S
    Am J Clin Dermatol; 2010; 11(1):45-50. PubMed ID: 20000874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.
    Cook VL; Meyer CT; Campbell NB; Blikslager AT
    Am J Vet Res; 2009 Aug; 70(8):992-1000. PubMed ID: 19645580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 in canine nasal carcinomas.
    Impellizeri JA; Esplin DG
    Vet J; 2008 Jun; 176(3):408-10. PubMed ID: 17517527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.
    Orsini JA; Ryan WG; Carithers DS; Boston RC
    Am J Vet Res; 2012 May; 73(5):664-71. PubMed ID: 22533398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.